News

Healio19h
Assay predicts adjuvant chemotherapy benefit in early-stage non-small cell lung cancer
A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...
The American Journal of Managed Care15h
Assay Finds Patients Who Will Benefit From Adjuvant Chemotherapy in Early-Stage NSCLC
Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...
MedPage Today on MSN20h
Gene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFS
CHICAGO -- Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to ...
The American Journal of Managed Care20h
Breaking Ground in Breast Cancer: A New Standard in TNBC, a New Way to Target ESR1
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...